CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-21 | dEsparbes Eric SVP and CFO | Sale | −1,825 | $12.07 | $22K | 354,296 |
| 2017-02-20 | Aguiar Michael W President & Chief Exec Officer | Shares withheld for taxes | −19,429 | $12.04 | $234K | 1,059,281 |
| 2017-02-20 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Shares withheld for taxes | −5,355 | $12.04 | $64K | 269,838 |
| 2017-02-20 | dEsparbes Eric SVP and CFO | Shares withheld for taxes | −8,604 | $12.04 | $104K | 356,121 |
| 2017-02-20 | Faerm Michael E. Sr VP & Chief Business Officer | Shares withheld for taxes | −5,860 | $12.04 | $71K | 287,747 |
| 2017-02-20 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Shares withheld for taxes | −6,367 | $12.04 | $77K | 253,782 |
| 2017-01-17 | Faerm Michael E. Sr VP & Chief Business Officer | Grant or award | +133,398 | 293,607 | ||
| 2017-01-17 | Aguiar Michael W President & Chief Exec Officer | Grant or award | +333,495 | 1,078,710 | ||
| 2017-01-17 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Grant or award | +106,718 | 275,193 | ||
| 2017-01-17 | dEsparbes Eric SVP and CFO | Grant or award | +133,398 | 364,725 | ||
| 2017-01-17 | WITEK THEODORE L JR Sr. VP & Chief Scientific Off. | Grant or award | +106,718 | 260,149 | ||
| 2016-11-21 | dEsparbes Eric SVP and CFO | Sale | −1,800 | $10.89 | $20K | 231,327 |
| 2016-11-20 | dEsparbes Eric SVP and CFO | Shares withheld for taxes | −3,832 | $10.91 | $42K | 233,127 |
| 2016-11-20 | Faerm Michael E. Sr VP & Chief Business Officer | Shares withheld for taxes | −2,893 | $10.91 | $32K | 160,209 |
| 2015-08-07 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +245,828 | $3,485,841.04 | $856.9B | 32,005,260 |
| 2015-05-11 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +85,579 | $1,369,264.00 | $117.2B | 31,759,432 |
| 2015-03-02 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +92,674 | $1,673,692.44 | $155.1B | 31,673,853 |
| 2014-11-04 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +832,456 | $12,786,524.16 | $10644.2B | 31,581,179 |
| 2014-08-11 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +172,651 | $3,912,271.66 | $675.5B | 30,748,723 |
| 2014-05-09 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +317,770 | $8,544,835.30 | $2715.3B | 30,576,072 |
Page 14 of 15 · 297 trades